胺碘酮治疗急性心肌梗死室性心律失常150例临床报告  

Clinical report of amiodarone on the treatment of ventriculararrhythmia in 150 patients with acute myocardial infarction

作　　者：刘刚[1] 

机构地区：[1]河南省安阳地区医院心内一科,455000

出　　处：《中国实用医药》2009年第31期29-31,共3页China Practical Medicine

摘　　要：目的评价胺碘酮治疗急性心肌梗死(acute myocardial infarction,AMI)室性心律失常的疗效和安全性。方法观察150例AMI患者采用胺碘酮治疗室性心律失常的疗效和安全性,随访1年。结果反复发作的持续性室速、室颤患者,首剂3～5mg/kg胺碘酮10min内静脉注射;再以1～1.5mg/min维持,室速均被有效终止。以200mg/d胺碘酮作为长期维持量能有效控制室性期前收缩。结论采用胺碘酮治疗AMI患者室性心律失常效果满意,安全可靠。Objective To evaluate the efieacy and safety of anfiodarone in the treatment of ventriculararrhythmia in patients with acute myocardial infarction. Methods One hundred and fifity patients with ventricular arrhythmia and acute myocardial infarction were treated with amiodarone and followed up oneyear. Resuits Intravenous loading dose of 3 - 5 mg/kg amiodarone was given within 10 minutes, followed by 1 - 1.5 mg/min infusion. The administration of amiodarone was effective in patients with recurrent sustained ventricular tachycardia and（or） fibrillation. Oral maintenance amiodarone dose of 200 mg/d could control ventricular arrythmia. Conclusion Amiodarone had high efficacy and was relatively safe for treating ventricular arrhythmia in pa- tient with acute myocardial infarction.

关 键 词：胺碘酮 急性心肌梗死 室性心律失常 随访 

分 类 号：R541.7[医药卫生—心血管疾病] R542.22[医药卫生—内科学]